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The recent 14th General Election signalled a 
fundamental change in the way this country had been 
governed since independent. For more than 6 decades, a 
single coalition government was in power, the victory 
of hope coalition parties or known as PH ushered a new 
era of change and enthusiasm with a genuine desire for 
good governance and transparency [1]. This is a calling 
that had permeated all government ministries [2] 
including the Ministry of Health (MOH). The 
appointment of an energetic yet ideological new health 
minister, an Imperial College London trained 
toxicologist to head the ministry and reign in all issues 
regarding health heightened the clamour to reform and 
improve our healthcare system, to face challenges of a 
changed nation and people, and the future. 
HOW ARE WE PERFORMING? 
As a nation, we attest to the importance of the principle 
universal health coverage or known as UHC; whereby 
the country will always seek to ensure that all her 
citizens have access to the required health services 
(promotive, preventive, curative and rehabilitative) of 
quality to be effective, and to ensure that the people do 
not suffer financial hardship to acquire these services2. 
To answer the question of performance, here are some 
recent external reviews of the performance and 
trajectory of our healthcare system. 
HARVARD SCHOOL OF PUBLIC HEALTH 
STUDY 
The Harvard TH Chan School of Public Health 
completed a comprehensive study of our healthcare 
system for the MOH in March 2016 [3]. In the report 
they concluded that our healthcare system is at a 
crossroad. Over the years, programs and plans have 
been very successful at meeting predetermined health 
challenges such as high levels of maternal mortality, 
infant mortality and under-five mortality, but the health 
system is ill-prepared to face new and rapidly evolving 
challenges the nation poses.  
  These challenges arise from significant 
demographic and epidemiological transitions, a shifting 
socio-cultural environment, technological changes and 
rising income levels, which have contributed to a 
nutritional transition, increasing health risks and new 
user expectations. I quote the report “in effect, Malaysia 
demonstrates a classic case of asymmetric transition, 
where the rapid transitions in context have not been 
matched with a corresponding transition in the health 
system to better address the current and future needs of 
the population.” While we rejoice at the excellent health 
achievements of the recent past, but we seem slow or 
even oblivious to the changing and evolving health 
needs of our people, somewhat emanating from the 
successes and highs of our own system and national 
policies. There is a need for a fundamental shift in 
approaches to healthcare delivery as a result.  
TRACKING UNIVERSAL HEALTH COVERAGE: 
2017 GLOBAL MONITORING REPORT 
In December 2017, a joint report [4], entitled above, 
was issued by the World Bank and World Health 
Organization on universal healthcare coverage and 
financing. As the title alludes, it scrutinises the 
worldwide performance of health systems in two major 
areas; UHC and catastrophic healthcare spending. The 
latter is defined as out-of-pocket expenditures (OOP) 
exceeding thresholds of more than 10% to 25% of 
household total income or consumption.  
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  In the summary, on the first count, Malaysia 
scored a UHC index of 70 out of 100 points, ranking a 
respectable fifth out of 48 Asian countries and just 
behind Singapore, Brunei, Japan, Korea (>80), China 
(76) and Vietnam (71). Similarly, on the financial risk 
aspect, we have emerged as one of the best in the world, 
scoring 0.74 and 0.04 at the 10% and 25% threshold 
respectively, which was even better than the UK (1.64; 
0.48) and US (4.77; 0.78). What makes these numbers 
even more significant, we have managed to attain these 
rankings through a very low healthcare expenditure, 
average of 4.5% of GDP or 9.4% of the total 
government budget for 2018. As a comparison, the total 
healthcare expenditure in Malaysia in 2016 was 
RM52.6bil, of which government contribution was 
51.47%, private OOP expenditure of 38.9% and private 
insurance 8%.  
  Worryingly however, the data shows a rapid 
rise of OOP from RM2.93bil in 1997 to RM17.44bil in 
2013, an average rise of nearly 29% per year with 
similar recorded trend of increase of nearly 52% in the 
private insurance sector over the same period. These 
trends exhibit the preference for the citizens to seek 
healthcare in the private sector which at the outset 
promises better access (avoiding significant delay and 
wait) and choice (first visit seeing consultant level 
practitioner and at preferred facility) and the overall 
service convenience (less congestion and hospital 
comfort) of the private sector. When OOP is used as 
option into private care, it increases the health gap and 
inequality in the healthcare costs, evident by 50% of the 
total health payment covering a meagre of only 20% of 
the population.  
  There is also the inherent risk of economic 
uncertainties or even downturns or other life challenges, 
which impact on income and therefore directly burden 
people’s health and cause serious repercussions in an 
OOP-dominant environment as we are seeing today. 
The reliance on OOP and private insurance for care 
delivery are highly inefficient and they are expensive, 
and akin to allowing the growth of an unregulated 
commercialisation of healthcare which in the end is 
detrimental to the overall healthcare delivery [5]. 
CATASTROPHIC ILLNESS HEALTH SPENDING  
This relates to the presence of a severe illness requiring 
prolonged hospitalisation for recovery, and inevitably 
results in expensive health spending. Our current 
healthcare coverage that includes a spectrum of 
catastrophic illnesses, which invariably incurs 
catastrophic health spending is highly variable. For 
example, coverage varies from universal cover for 
cataract surgery, dialysis, medicines for organ 
transplant and CML (chronic myeloid leukaemia) and 
dialysis, to practically non-existent for HCV (hepatitis 
C virus), stroke, epilepsy surgery or psoriasis. In 
another category, the coverage for some targeted 
therapies for knee replacement surgery, solid cancers, 
coagulation factors for haemophilia and anti-TNF for 
arthritis were poor, while coronary revascularisation, 
epoetin and anti-retrovirals and iron chelation for 
thalassaemia were insufficient.  
  The coverage for catastrophically costly 
treatments is uneven and inequitable in Malaysia. 
Despite many of these treatments are in fact affordable, 
on many occasions the coverage decisions are driven by 
inexplicable political-economic consideration. In one 
study that was conducted in many countries in ASEAN, 
it found that Malaysians (45%) are most likely to suffer 
economic hardship following a cancer diagnosis 
compared to the people in Indonesia (42%), and 
Thailand (16%) [6].  
GLOBAL BURDEN OF DISEASE ON 
HEALTHCARE ACCESS AND QUALITY  
A comparative study, the 2015 Global Burden of 
Disease, estimated the measure of healthcare access and 
quality (HAQ) index to enable comparisons to be made 
among 195 countries in the world from 1990 to 2016 
[7]. The index is based on amenable mortality, defined 
as risk-standardised mortality rates or mortality-to-
incidence ratios from causes that, in the presence of 
quality healthcare, should not result in death. The HAQ 
Index encompasses 32 causes of death considered to be 
avoidable, and they include infectious diseases; 
maternal and child health; vaccine-preventable diseases; 
non-communicable diseases, including cancers, 
diabetes and cardiovascular diseases; and conditions in 
gastrointestinal system (e.g. appendicitis) from which 
death can easily be avoided by surgery. All the causes 
are measured on a scale of 0 to 100, with 0 as the first 
percentile (the worst), and 100 as the 99th percentile 
(the best) [8]. 
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  On these scales, Malaysia obtained an HAQ 
index of 68 and thus ranked 84th, but surpassed by all 
our near neighbours; Singapore, Brunei, and Thailand, 
the best in the region being Singapore, ranked 22nd 
with a HAQ index of 91. There is a great consternation 
in this fact, HAQ index for Malaysia, Sri Lanka and 
Thailand Malaysia were somewhat pegged in 2000, but 
a decade and a half later, both Sri Lanka and Thailand 
leapfrogged us resulting in their significantly better 
ranking.  
DIFFERENTIAL MORTALITY 
It is well known that our healthcare is geographically 
uneven and in some areas numerically incoherent to 
health needs and demands, and the results from a local 
study [9] from an anonymised mortality data from 1998 
to 2006 from the Statistics Department is important to 
elucidate this aftermath. The authors found that socially 
disadvantaged districts in Malaysia had worse mortality 
outcomes compared to more advantaged districts. The 
mortality outcomes within ethnic groups were less 
favourable among the poor and premature mortality was 
concentrated among the poor of every ethnic group. 
They concluded that the findings suggest that national 
policies should emphasise the degree of need rather 
than ethnic-based policies to ensure that support is 
provided and distributed in an equitable manner. This is 
vital to prevent the gradient in health from becoming 
any steeper.  
HEALTHCARE REFORM 
The healthcare challenges our country faces are 
complex, multifaceted and interconnected and therefore 
the reforms will take time because some aspects are 
fundamental in nature, and will be slow because of 
system inertia and old mindset, but the changes are 
necessary as the present system is unsustainable and 
unstable, “while transformative change cannot be 
achieved overnight, Malaysian policymakers would be 
wise to implement stepwise innovations which will 
strengthen the Malaysian health system in order to more 
effectively address population needs and changes in the 
national context” [10]. 
  The reform strategies and solutions require the 
participation of all stakeholders in the public and 
private sectors including the feedback from patients’ 
groups and relevant welfare advocacy organisations. 
This is imperative as patient engagement is at the heart 
of accessible and safe care that is vital to achieving 
UHC goals and support the United Nations Sustainable 
Development Goals which prioritises healthy living and 
promotes well-being for all. 
  Healthcare reforms can be viewed as short 
term and long term. In the short term, the current 
administrative practices and cultures should be 
improved or revamped to avoid wastage, overlap, 
redundancies and uneconomical practices. Examples 
include overlapping committees or units, poor 
procurement or purchasing practices and processes, 
overlapping responsibilities, and overlapping new 
portfolios with already in existent in other ministries 
such as medical education and training. As the pertinent 
issues are numerous and interrelated and sometimes 
institutionalised; an internal self-induced reform will be 
superficial and cursory, thus an independent committee 
of previous health experts headed by a senior lawmaker 
should be useful to guide the process through.  
  Long term reforms are designed to stop and 
reverse the negative trends we see in the international 
reports that have been alluded to above. First, the 
primary health services (public and private) need a 
major and thorough reform to ensure that they become 
the gatekeep of secondary and tertiary healthcare in this 
country. This will maximise use of available resources 
for optimum healthcare, avoid health system abuse 
especially secondary care, ensure tight monitor and care 
of exploding non-communicable diseases among the 
population, and provide a good value for expenditure on 
healthcare. Data are awash on the benefits of a 
comprehensive primary healthcare provision that 
ensures a nationwide coverage. We have a disjointed 
provision of private and public primary care services, 
the former with the tendency for overlaps and unused 
capacity at the same time stretching resources in the 
public sector to the limit.  
  Second, there must be a meaningful and 
mutually beneficial partnership between the private and 
public healthcare providers, the latter is bursting with 
increasing demands for its services and the opposite for 
the former with extra capacity. The combination of 
clinics and family medicine specialists from both 
private and public sectors will be adequate to set the 
scene for a comprehensive primary care service where 
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an individual is accorded a family doctor for primary 
healthcare. For secondary and tertiary care, private 
hospitals could provide the extra beds and facilities 
required to reduce the pressure on government hospitals 
and ensure better healthcare delivery to the people. 
  Thirdly, there must be a new healthcare 
financing scheme to fund the healthcare delivery in the 
country. The present setup in both public and private is 
unstable and unsustainable. This is a major shift in 
healthcare policy and requires a bipartisan approval at 
the parliament because the implication is far and wide 
for the country. 
  Lastly, there must be a major revamp on the 
roles of MOH to allow a more focused, and 
decentralised MOH to monitor and regulate the 
healthcare delivery in the country. MOH should be 
lean, in doing so minimise or even forsake overlapping 
roles with other ministries such as medical education 
and training, research and development, and health 
financing. In the long term, MOH should ideally be 
devolved into independent regional health authorities 
where they can operate hospitals and clinics with 
autonomy but with greater accountability and scrutiny 






Accessed 15th October 2018. 
2. Highlights of the Mid-Term Review of the 
11th Malaysia Plan. 
http://www.theedgemarkets.com/article/highli
ghts-midterm-review-11th-malaysia-plan. 
Accessed 1st November 2018 
3. Ng CW. Universal Health Coverage 
Assessment: Malaysia. Global Network for 
Health Equity (GNHE). 2015. International 
Development Research Centre (IDRC), 
Ottawa, Canada. 
4. Tracking universal health coverage: 2017 
Global Monitoring Report 
http://pubdocs.worldbank.org/en/19337151316
9798347/2017-global-monitoring-report.pdf. 
Accessed 10th October 2018. 
 
5. Chan M & Brundtland GH. Universal Health 
Coverage: An affordable goal for all. 2016. 
World Health Organization (WHO). 
http://www.who.int/mediacentre/commentarie
s/2016/universal-health-coverage/en/. 
Accessed 15th October 2018. 
6. Bhoo-Pathy N, Yip CH, Peters SA, Kimman 
M, Sullivan R, Jan S, Woodward M, Ng CW, 
Arounlangsy P, Aung S, Balete SL. Policy and 
priorities for national cancer control planning 
in low-and middle-income countries: Lessons 
from the Association of Southeast Asian 
Nations (ASEAN) Costs in Oncology 
prospective cohort study. European Journal of 
Cancer. 2017; 74: 26-37. 
7. Fullman N, Yearwood J, Abay SM, Abbafati 
C, Abd-Allah F, Abdela J, Abdelalim A, 
Abebe Z, Abebo TA, Aboyans V, Abraha HN. 
Measuring performance on the Healthcare 
Access and Quality Index for 195 countries 
and territories and selected subnational 
locations: A systematic analysis from the 
Global Burden of Disease Study 2016. The 
Lancet. 2018; 391(10136): 2236-71. 
8. Foreman KJ, Marquez N, Dolgert A, Fukutaki 
K, Fullman N, McGaughey M, Pletcher MA, 
Smith AE, Tang K, Yuan CW, Brown JC. 
Forecasting life expectancy, years of life lost, 
and all-cause and cause-specific mortality for 
250 causes of death: Reference and alternative 
scenarios for 2016–40 for 195 countries and 
territories. The Lancet. 2018; 392(10159): 
2052-90. 
9. Mariapun J, Hairi NN, Ng CW. Are the poor 
dying younger in Malaysia? An examination 
of the socioeconomic gradient in mortality. 
PloS one. 2016; 11(6): e0158685. 
10. Malaysia Health Systems Research Volume I. 
Contextual Analysis of the Malaysian Health 
System, March 2016. 
http://www.moh.gov.my/penerbitan/Laporan/
Vol%201_MHSR%20Contextual%20Analysis
_2016.pdf. Accessed 18th December 2018 
 
         
         
